Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SKYE compared with TRDA: revenue, margins and what each company keeps, and the suppliers and customers both name
SKYE
Skye Bioscience, Inc.
Change
Mkt cap
Revenue
Revenue
TRDA
Entrada Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
SKYE
Skye Bioscience, Inc.
vs
TRDA
Entrada Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
SKYE
Skye Bioscience, Inc.
Change
1.34
▲
+4.67%
· post 1.33
· delayed
Mkt cap
$5.7M
Revenue
—
Revenue
—
TRDA
Entrada Therapeutics, Inc.
Change
5.11
▲
+12.65%
· post 5.07
· delayed
After hours
Nov 2 '26
delayed
Mkt cap
$176.6M
Revenue
$898,000
Q2 FY26
Revenue
$25M
FY25
vs
Compare
After hours
Nov 2 '26
delayed
SKYE
Skye Bioscience, Inc.
vs
TRDA
Entrada Therapeutics, Inc.
1.34
▲
+4.67%
post 1.33
delayed
Price
5.11
▲
+12.65%
post 5.07
delayed
$5.7M
Mkt cap
$176.6M
—
Revenue
$898,000
Q2 FY26
—
Revenue
$25M
FY25
Change
Change
SKYE
1.34
▲
+4.67%
vs
TRDA
5.11
▲
+12.65%
After hours
Nov 2 '26
delayed
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
SKYE: latest quarter not drawable. TRDA: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only SKYE
1
HALO
Halozyme
supplier
Shared
0
No shared counterparties.
Only TRDA
3
VRTX
Vertex Pharmaceuticals
customer
—
Ohio State Innovation Foundation
unlisted
supplier
—
Pierrepont Therapeutics
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
SKYE, solid
TRDA, dashed